Biohaven Ltd. (BHVN) is a publicly traded Healthcare sector company. As of October 15, 2026, BHVN trades at $11.40 with a market cap of $1.65B and a P/E ratio of -1.76. BHVN moved +4.57% today. Year to date, BHVN is +5.44%; over the trailing twelve months it is -34.16%. Its 52-week range spans $7.48 to $38.23. Analyst consensus is buy with an average price target of $19.63. Rallies surfaces BHVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for BHVN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $11.40 |
| Market Cap | $1.65B |
| P/E Ratio | -1.76 |
| EPS | $-6.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $38.23 |
| 52-Week Low | $7.48 |
| Volume | 342.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-738.82M |
| Gross Margin | 0.00% |
11 analysts cover BHVN: 0 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.63.